跳至主要内容
临床试验/NCT01458873
NCT01458873Unknown2 期

Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
20
试验地点
1
主要终点
transient increase in end tidal carbon dioxide

研究概览

简要总结

Vascular access in patients carries a significant risk of accidental extravasation of intravenous (IV) fluids and medications with the potential for tissue injury. This prospective controlled study assessed the diagnostic utility of using intravenous diluted sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the injected bicarbonate will dissolve into carbon dioxide and water and cause a transient increase in the measured exhaled CO2.

The effect is unique to bicarbonate and will not appear once normal saline is injected. the safety of the administration of bicarbonate on the metabolic profile of the volunteers will be assessed by measurement of venous blood pH and electrolytes.

详细描述

Vascular access in patients carries a significant risk of accidental extravasation of intravenous (IV) fluids and medications with the potential for tissue injury. This prospective controlled study assessed the diagnostic utility of using intravenous diluted sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the injected bicarbonate will dissolve into carbon dioxide and water and cause a transient increase in the measured exhaled CO2. Arbitrary increase of more than 10%in end-tidal carbon dioxide is considered as a positive response.

The effect is unique to bicarbonate and will not appear once normal saline is injected. the safety of the administration of bicarbonate on the metabolic profile of the volunteers will be assessed by measurement of venous blood pH and electrolytes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • no cardiovascular or respiratory disease

排除标准

  • ASA > II
  • Cardiovascular disease
  • Respiratory disease
  • renal failure
  • metabolic alkalosis

研究组 & 干预措施

sodium bicarbonate 4.2%

Experimental

sodium bicarbonate 4.2% 50 m"l

干预措施: sodium bicarbonate 4.2% (Drug)

sodium bicarbonate 2.1%

Experimental

sodium bicarbonate 2.1% 1 50 m"l

干预措施: diluted sodium bicarbonate 2.1% (Drug)

normal saline

Placebo Comparator

50 m"l normal saline

干预措施: normal saline (Drug)

结局指标

主要结局

transient increase in end tidal carbon dioxide

时间窗: 4-12 seconds

Once sodium bicarbonate is injected the measured end-tidal carbon dioxide will transiently increase by at least 10% of baseline

次要结局

  • Change in venous blood pH(10-20 minutes)
  • Subjective adverse symptoms associated with injection of sodium bicarbonate(1 minute)
  • change in venous blood sodium(10- 20 minutes)
  • change in venous blood bicarbonate level(10-20 minutes)
  • change in venous blood potasium level(10-20 minutes)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Ilan Keidan

Director, Pediatric Anesthesia, Sheba Medical center

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验